Inflammatory rheumatologic disorders in the elderly. Unusual presentations, altered outlooks.
Comorbidities, metabolic alterations, immunosenescence, and use of drugs may affect the manifestation, clinical course, immunopathogenesis, and prognosis of inflammatory rheumatologic disease in older persons. These factors need to be considered in evaluation and treatment in the geriatric population. In this article, Drs Belostocki and Paget discuss rheumatologic disorders that typically occur in advanced age, as well as those that characteristically occur in younger patients but may present de novo in the elderly.
Belostocki
Kristina B
KB
Division of Rheumatology, Hospital for Special Surgery, Cornell University Joan and Sanford I. Weill Medical College, Graduate School of Medical Sciences, New York, NY, USA. belostocki@hss.edu
Paget
Stephen A
SA
D000367:Age Factors; D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015897:Comorbidity; D005260:Female; D006801:Humans; D007249:Inflammation; D008297:Male; D011379:Prognosis; D012216:Rheumatic Diseases / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology
D018501:Antirheumatic Agents